IPP Bureau
Health Minister Nadda inaugurates ‘First Policy Makers’ Forum’ in New Delhi
By IPP Bureau - August 20, 2024
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
By IPP Bureau - August 20, 2024
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Health Minister Nadda reviews Monkeypox situation and preparedness
By IPP Bureau - August 19, 2024
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
Health Ministry assures doctors of all possible efforts to ensure safety
By IPP Bureau - August 19, 2024
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
CIDSCON 2024 discusses actionable efforts to tackle antimicrobial resistance
By IPP Bureau - August 19, 2024
The emergence of new infections in India is a growing concern
ANVISA completes inspection at Caplin Steriles' facility at Gummidipoondi
By IPP Bureau - August 19, 2024
Zydus Lifesciences to scale up US specialties business
By IPP Bureau - August 19, 2024
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Allozymes partners with Adisseo on next-gen animal feed production
By IPP Bureau - August 19, 2024
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
By IPP Bureau - August 19, 2024
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
EMA validates Bristol Myers Squibb’s application for CAR T cell therapy Breyanzi for relapsed or refractory follicular lymphoma
By IPP Bureau - August 19, 2024
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Aptar’s nasal unidose system delivers FDA-approved neffy
By IPP Bureau - August 19, 2024
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Lupin receives USFDA’s tentative approval for Brimonidine Tartrate Ophthalmic Solution
By IPP Bureau - August 17, 2024
Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC) is indicated to relieve redness of the eye due to minor eye irritations.
Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer
By IPP Bureau - August 17, 2024
Based on AEGEAN Phase III trial results which showed Imfinzi-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy alone
Fortis Hospital Mulund hosts India's first IFEM endorsed ECMO workshop for emergency medicine doctors
By IPP Bureau - August 16, 2024
This two-day program was attended by 40 doctors & paramedical staff
